Description
This blend contains:
GHK-Cu, used in ECM and dermal-biology research;
BPC-157, applied to models of connective-tissue and organ protection;
TB-500, a thymosin ?4 fragment used to study actin-mediated motility and angiogenesis; and KPV, a melanocortin-derived tripeptide that has been studied in colitis, skin, and lung models for its influence on inflammatory signaling and epithelial repair.
Researchers employ Klow Blend where inflammation, barrier function, and structural remodeling all play important roles, for example, in gastrointestinal, cutaneous, or respiratory epithelial models. KPV has been shown in preclinical work to interact with NF-?B-related pathways and to support epithelial integrity, making it a logical complement to the matrix- and actin-focused peptides in this formulation.
